330 related articles for article (PubMed ID: 27502600)
21. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G
Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
Ge Y; Lu X; Peng Q; Shu X; Wang G
PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
[TBL] [Abstract][Full Text] [Related]
23. Serum concentrations of vascular endothelial growth factor in collagen diseases.
Kikuchi K; Kubo M; Kadono T; Yazawa N; IHN H; Tamaki K
Br J Dermatol; 1998 Dec; 139(6):1049-51. PubMed ID: 9990370
[TBL] [Abstract][Full Text] [Related]
24. Large macrophage colony-forming cells identical to high proliferative potential colony-forming cells in peripheral blood of patients with collagen vascular diseases: high occurrence among patients with systemic sclerosis and dermatomyositis.
Horie S; Minota S; Kano S
J Rheumatol; 2000 Oct; 27(10):2378-81. PubMed ID: 11036833
[TBL] [Abstract][Full Text] [Related]
25. Detection of large macrophage colony forming cells in the peripheral blood of patients with rheumatoid arthritis.
Horie S; Nakada K; Masuyama J; Yoshio T; Minota S; Wakabayashi Y; Hirose S; Kano S
J Rheumatol; 1997 Aug; 24(8):1517-21. PubMed ID: 9263144
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum YKL-40 correlates with clinical characteristics in patients with polymyositis or dermatomyositis.
Gao MZ; Wei YY; Xu QW; Ji R; Han ZJ; Jiang TW
Ann Clin Biochem; 2019 Jan; 56(1):95-99. PubMed ID: 30019588
[TBL] [Abstract][Full Text] [Related]
27. The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy.
Zhang YM; Yang HB; Shi JL; Chen H; Shu XM; Lu X; Wang GC; Peng QL
Clin Rheumatol; 2018 Jun; 37(6):1573-1580. PubMed ID: 29541951
[TBL] [Abstract][Full Text] [Related]
28. Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis.
Tatebe N; Sada KE; Asano Y; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Katsuyama T; Katsuyama E; Watanabe H; Narazaki M; Watanabe K; Kawabata T; Wada J
Mod Rheumatol; 2018 Jan; 28(1):141-146. PubMed ID: 28463039
[TBL] [Abstract][Full Text] [Related]
29. Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry.
Nuño-Nuño L; Joven BE; Carreira PE; Maldonado-Romero V; Larena-Grijalba C; Llorente Cubas I; Tomero E; Barbadillo-Mateos MC; García de la Peña Lefebvre P; Ruiz-Gutiérrez L; López-Robledillo JC; Moruno-Cruz H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; García de Yébenes MJ; López-Longo FJ
Int J Rheum Dis; 2019 Aug; 22(8):1393-1401. PubMed ID: 30968571
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
Gabay C; Gay-Croisier F; Roux-Lombard P; Meyer O; Maineti C; Guerne PA; Vischer T; Dayer JM
Arthritis Rheum; 1994 Dec; 37(12):1744-51. PubMed ID: 7986220
[TBL] [Abstract][Full Text] [Related]
31. Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases.
Shen H; Xia L; Lu J
Cytokine; 2012 Nov; 60(2):334-7. PubMed ID: 22863719
[TBL] [Abstract][Full Text] [Related]
32. Serum level of DNase1l3 in patients with dermatomyositis/polymyositis, systemic lupus erythematosus and rheumatoid arthritis, and its association with disease activity.
Zhao Q; Yang C; Wang J; Li Y; Yang P
Clin Exp Med; 2017 Nov; 17(4):459-465. PubMed ID: 28039554
[TBL] [Abstract][Full Text] [Related]
33. Elevated serum soluble CD27 levels are associated with both disease activity and humoral immune activity in patients with rheumatoid arthritis.
Shi L; Yang J; Xu J; Dai J; Li J
Clin Exp Rheumatol; 2024 May; 42(5):983-990. PubMed ID: 38179730
[TBL] [Abstract][Full Text] [Related]
34. [The levels and clinical significance of serum B cell activating factor in Chinese patients with polymyositis or dermatomyositis].
Peng QL; Xie Y; Zhang RF; Shu XM; Wang GC
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):210-3. PubMed ID: 22781895
[TBL] [Abstract][Full Text] [Related]
35. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
Chen F; Shu XM; Wang DX; Xie Y; Wang GC
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
[TBL] [Abstract][Full Text] [Related]
36. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
[TBL] [Abstract][Full Text] [Related]
37. Serum interleukin-6 expression level and its clinical significance in patients with dermatomyositis.
Yang M; Cen X; Xie Q; Zuo C; Shi G; Yin G
Clin Dev Immunol; 2013; 2013():717808. PubMed ID: 24082909
[TBL] [Abstract][Full Text] [Related]
38. International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis.
Lakota K; Thallinger GG; Sodin-Semrl S; Rozman B; Ambrozic A; Tomsic M; Praprotnik S; Cucnik S; Mrak-Poljsak K; Ceribelli A; Cavazzana I; Franceschini F; Vencovsky J; Czirják L; Varjú C; Steiner G; Aringer M; Stamenkovic B; Distler O; Matucci-Cerinic M; Kveder T
Arthritis Res Ther; 2012 Jan; 14(1):R2. PubMed ID: 22226402
[TBL] [Abstract][Full Text] [Related]
39. Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies.
Notarnicola A; Lapadula G; Natuzzi D; Iannone F
Reumatismo; 2014 Nov; 66(3):215-23. PubMed ID: 25376956
[TBL] [Abstract][Full Text] [Related]
40. Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
Chen HH; Chao WC; Liao TL; Lin CH; Chen DY
PLoS One; 2018; 13(7):e0201340. PubMed ID: 30048527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
